Skip to content
Review

[Vaccination against respiratory infections in older adults: Covid-19, respiratory syncytial virus, influenza and pneumococcus].

Sep 2026 · Gériatrie et Psychologie Neuropsychiatrie du Vieillissement · Vol 24 3, pp. 261-270 · 0 citations
Medicine

TL;DR

This review provides an update on four vaccine-preventable respiratory infections that are particularly common or severe in older adults: coronavirus disease 2019 (COVID-19), respiratory syncytial virus (RSV) infection, seasonal influenza, and pneumococcal disease.

Abstract

Population aging increases the risk of severe respiratory infections and their complications in older adults, largely because of immunosenescence. Beyond pneumonia, these infections can lead to cardiac and respiratory decompensation, acute cardiovascular events, loss of functional independence, and institutionalization. Vaccination remains the cornerstone of prevention. This review provides an update on four vaccine-preventable respiratory infections that are particularly common or severe in older adults: coronavirus disease 2019 (COVID-19), respiratory syncytial virus (RSV) infection, seasonal influenza, and pneumococcal disease. For each infection, we review the epidemiological burden, associated complications-particularly cardiovascular and functional outcomes-as well as recent real-world evidence on vaccine effectiveness and the 2026 French recommendations. The evidence is consistent: safe and effective vaccines are available for all four infections, yet vaccination coverage remains far below target among older adults and is even lower among healthcare workers, a situation that has worsened since the COVID-19 pandemic. The pandemic has durably reshaped attitudes towards vaccination, shifting from initial acceptance to growing hesitancy. Improving information and education for both the public and healthcare professionals, particularly those working in geriatric care settings, appears to be the most effective strategy for reducing this preventable burden. Clear, consistent communication and the integration of vaccination into personalized care plans are essential to translate well-established recommendations into effective protection.

View source

Similar papers

Open access Sep 2026

Burden of Pneumonia in Older Adults and the Role of Immunization

Lower respiratory infections remain the leading infectious cause of death worldwide, with pneumonia causing a substantial burden of morbidity, mortality, and long-term complications in older adults, particularly among those with chronic comorbidities, immunocompromising conditions, or those living in nursing homes. Str...

Catia Cillóniz, Alejandro Videla, R. Guglielmi · 0 citations
Review Open access Oct 2026

Respiratory Syncytial Virus Vaccines: Who, When, and Which Vaccine? A Practical Guide for Clinicians

Respiratory syncytial virus (RSV) is a major cause of severe respiratory illness and hospitalization in older adults with chronic cardiopulmonary or metabolic conditions. After six decades without a preventive option, three RSV vaccines are now available: an adjuvanted prefusion F protein vaccine (Arexvy), a bivalent p...

Raeseok Lee · 0 citations
Review Open access Nov 2026

Respiratory syncytial virus (RSV) vaccine recommendations for adults: a review of available global, regional, and country level recommendations.

INTRODUCTION Respiratory syncytial virus (RSV) can cause serious disease in older adults (OAs), particularly those with underlying medical conditions. It can lead to acute respiratory illness and lower respiratory tract infections in adults ≥60 years and at increased risk groups. RSV morbidity, mortality, and health ca...

Otávio Cintra, Abhay Phansalkar, M. Laucho-Contreras et al. · 1 citation

From Evidence to Implementation

Respiratory syncytial virus (RSV) is a leading cause of acute lower respiratory infections in young children. In 2019, RSV was estimated to cause approximately 33 million acute lower respiratory infections, 3.6 million hospitalisations and more than 101,000 deaths among children under five years of age, with more than...

N. Rave · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.